RxDoctor Payments DataLook up a doctor →

Dinesh Kalra, MD

Cardiovascular Disease · Louisville, KYNPI 1184660912

Payments from drug & device makers

$739,148in general payments, 2019–2025

Across 532 payments — averaging $1389.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cleerly, Inc.$179K
  • Novartis$128K
  • Sanofi$90K
  • Amgen$73K
  • Alnylam Pharmaceuticals Inc.$62K
  • Pfizer$59K
  • plus $148K from 16 others

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$739,148 in reported general payments places this provider in the 95th percentile of 258 cardiovascular disease providers in Kentucky.

See all cardiovascular disease providers in Kentucky

Medicare billing

Part B allowed, 2024
$19,401
Medicare patients
85
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →